Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 论文

2021Nature Communications引用 293顶会
DOIPDF
SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies
Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
相关技术:Computational Drug Discovery Methods
关系图谱

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 · 相关技术

相关技术

Computational Drug Discovery Methods